Rise Advisors’s Arcosa ACA Stock Holding History

Rise Advisors’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-128	Closed	-$12K	–	107
2025 Q3	$12K	Hold	128	–	–	﹤0.01%	893
2025 Q2	$11.1K	Hold	128	–	–	﹤0.01%	933
2025 Q1	$9.87K	Buy	+128	New	+$11.7K	﹤0.01%	979

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rise Advisors's ACA Position: Q4 2025 in Review

Rise Advisors sold out of Arcosa (ACA) in Q4 2025, closing a stake of 128 shares — an estimated $12K sold.

Rise Advisors first reported a position in ACA in Q1 2025 and held it in 3 quarters. The position peaked at $12K in Q3 2025. 364 funds tracked by Wall St. Rank hold ACA as of Q4 2025.

Rise Advisors reported no remaining Arcosa position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 128 Arcosa shares in Q4 2025, an estimated $12K.
Rise Advisors first reported a position in Arcosa in Q1 2025 and held it in 3 quarters.
Rise Advisors's Arcosa position peaked at $12K in Q3 2025.
364 funds tracked by Wall St. Rank held Arcosa as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.